Sacubitril/valsartan is well tolerated in patients with longstanding heart failure and history of cancer and improves ventricular function: real-world data.

Frey, Maria Klara; Arfsten, Henrike; Pavo, Noemi; Han, Emilie; Kastl, Stefan; Hülsmann, Martin; Gyöngyösi, Mariann; Bergler-Klein, Jutta

Frey, Maria Klara; Arfsten, Henrike; Pavo, Noemi; Han, Emilie; Kastl, Stefan; Hülsmann, Martin; Gyöngyösi, Mariann; Bergler-Klein, Jutta.

Affiliation

Frey MK; Department of Cardiology, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Arfsten H; Department of Cardiology, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Pavo N; Department of Cardiology, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Han E; Department of Cardiology, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Kastl S; Department of Cardiology, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Hülsmann M; Department of Cardiology, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Gyöngyösi M; Department of Cardiology, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Bergler-Klein J; Department of Cardiology, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. jutta.bergler-klein@muv.ac.at.

Cardiooncology ; 7(1): 35, 2021 Oct 13.

Article de En | MEDLINE | ID: mdl-34645527

Mots clés

ARNI; Cancer; Cardio-oncology; Cardiotoxicity; Heart failure; Natriuretic peptides; Sacubitril-valsartan

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: En Journal: Cardiooncology Année: 2021 Type de document: Article Pays d'affiliation: Autriche

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google